Thu, Apr 17, 2014, 6:53 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

surfer_bj 109 posts  |  Last Activity: 21 hours ago Member since: Sep 28, 2001
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Life is very unpredictable, but I would definitely give PPHM at this point a very high grade on it's future in creating some blockbuster drugs. One does not know what could spark the next stock movement, but it has a high probability that when you least expect it, it will happen....
    PPHM'S pipeline growth could double between 2014 and 2015. PPHM will continue to have many
    Phase I, Phase II and Phase III trials going forward for FDA approvals, one after another with sales funding the next drug trial. They are lining up their trials all in a row, just like baby ducks following their mother. Only it will be PPHM'S main drug Bavituximab that is the mother of new trials going forward.

    Sentiment: Strong Buy

  • surfer_bj surfer_bj 21 hours ago Flag

    Where were you and your bloody remarks when PPHM stock was moving fast forward over $3 for several weeks? How much bloody money did you make shorting PPHM under $2 . If I figure it you just broke even.
    A loss on the way up and a gain moving down = a bloody wash...

    If you are smart ( I doubt that) you whould be buying PPHM shares in this range for the bullet train ride up.

    Sentiment: Strong Buy

  • Reply to

    What I don't get!!!

    by mistarichter Apr 3, 2014 9:52 PM
    surfer_bj surfer_bj Apr 3, 2014 11:55 PM Flag

    The bashers afraid to admit they were wrong, ARNA'S diet drug BELVIQ, is the one that is strong and growing stronger.
    Don't let your ego get in your way, because it's only going to get worse if your short. The Safer drug with safe results and with other new combos and choices, is always 1st choice and best seller in the long term. You can see what happened to vvus and could happen to OREX if they are lucky enough to pass FDA without any warnings and sales on their label.

    Sentiment: Strong Buy

  • surfer_bj surfer_bj Apr 2, 2014 1:54 PM Flag

    PPHM Is Forming into the next major Biotech company. They are taking to right steps creating a huge pipeline of drugs that will continue to add value to the company. In the future, there will always be the next phase III drug making way to FDA approval. PPHM will be able to control all their drugs by manufacturing them through their own manufacturing plant thru Avid.

    It's going to be a win, win for all investors noting their expected future sales and growth....$$$

    So short all you want if that's if you like watching your investments disappear.

    Sentiment: Strong Buy

  • Reply to

    PARTNERSHIP= FRUITION= BAG OF CASH

    by americandad71 Mar 28, 2014 4:42 PM
    surfer_bj surfer_bj Mar 28, 2014 5:52 PM Flag

    The further along the trials move, especially Phase three Fast Track, partners will be offering much higher deals. As the other trials move forward into phase I, II and phase III trials, PPHM'S value will grow many times more than todays value. Add AVID'S growth to the pot of gold, and you can see more growth value continue going forward.

    Any new future debt for the progress of the trials will be offset by their value of growth mentioned above and even more so when partners start coming aboard.

    Within a few years the Fast Track should be completed and ready for FDA approval and product sales. The 1st product will pay for other trials that will be moving forward through phase III FDA approvals.

    If there are only few bumps in the road, PPHM is looking for a very lucrative future and some possible blockbuster products.

    Sentiment: Strong Buy

  • Reply to

    Why so quiet today Empire?

    by robtmsstt22 Mar 27, 2014 1:45 PM
    surfer_bj surfer_bj Mar 27, 2014 2:01 PM Flag

    Has sore carpal tunnel ..resting them on up days....

    Sentiment: Strong Buy

  • Biopharmaceutical Stocks Are Down 15% From February Highs (IBB $239.5)
    The abrupt sell-off in the sector may be the result of:
    •Excessive speculation, 54 Biotech IPOs.
    •Geopolitical concerns like China economy and Ukraine.
    •Pricing and reimbursement issues with high priced drugs.
    •Profit taking after huge moves YTD and in 2013.
    •Re-balancing of stock portfolios toward economic recovery.

    From a Seeking Alpha article: Stated above, large cap Biopharmaceutical Stocks has triggered the biotech sector in a recent decline. More so with small cap as many are at recent highs for the year.

    All this noise about PPHM insiders causing the stock to melt down, is a lot of hogwash! It's big hedge funds shorting and running the market. Noticed recently on many stocks boards many new short names this month. It's a fools game they play.

    Sentiment: Strong Buy

  • Reply to

    Hopefully this steaming pile of manure

    by oceanbreeze7us Mar 25, 2014 11:49 PM
    surfer_bj surfer_bj Mar 26, 2014 12:09 AM Flag

    Hopefully these creepy crawlers all over the message board blow out to sea with a huge big wave from a big oceanbreeze created from PPHM'S management...It'll happen when they least expect it...and next time there will be no turning back...

    PPHM pipeline growth continues with high speed....

    Sentiment: Strong Buy

  • surfer_bj surfer_bj Mar 25, 2014 3:26 PM Flag

    Based on ARNA'S performances they will only continue to grow and grow. Shorts will wake up one day and find yourselves bankrupted. It's inevitable that at some point will pay for all the lies and bashing they do.

    Sentiment: Strong Buy

  • surfer_bj surfer_bj Mar 25, 2014 2:38 PM Flag

    Now you can't claim management is insider trading. Management may have a policy about share purchase. I have seen many companies with management owns no shares or a very limited amount.

    I do remember big stink about VVUS management selling a lot of shares at the top. Recently Gale's management selling at the top. Now you understand that even if it was not intended, they still get called on for doing so.

    So now you shorts have that much less to accuse ARENA'S management for doing their job.

    Sentiment: Strong Buy

  • Coast Guard officials said that up to 168,000 gallons were dumped after one of the barge's tanks ruptured and that oil had been detected 12 miles offshore in the Gulf of Mexico as of Sunday afternoon.
    "It will take quite a bit of time, given the complexity of the vessels and a very busy waterway," Penoyer said.
    The contents of the torn tank, equal to about 4,000 barrels, were lost or displaced into other vacant areas of the barge. Penoyer said currents, tides and wind were scattering the spill.

    There was no timetable for a total reopening of the channel, which typically handles as many as 80 vessels daily.

    The channel, one of the world's busiest waterways for moving petrochemicals, was shut for a second day Sunday. As many as 60 vessels were backed up both trying to get out and get in.

    PETROCHEMICALS
    Ethanol, also known as ethyl alcohol or grain alcohol, is a flammable, colorless, mildly toxic chemical compound with a distinctive odor, and is the alcohol found in alcoholic beverages. In common usage, it is often referred to simply as alcohol. Its molecular formula is C2H6O, variously represented as EtOH, C2H5OH or as its empirical formula C2H6O.

    Ethanol is produced both as a petrochemical, through the hydration of ethylene, and biologically, by fermenting sugars with yeast.

    Sentiment: Strong Buy

  • surfer_bj surfer_bj Mar 23, 2014 5:47 PM Flag

    That's why shorts are trying to work on you emotions. Fact!

    Sentiment: Strong Buy

  • Reply to

    Why a preferred deal?

    by fiduciarydoozy Mar 22, 2014 3:40 PM
    surfer_bj surfer_bj Mar 23, 2014 4:57 PM Flag

    They have no worry for paying their 10%, AVID is their backup money maker. Management already stated that and said the reason is because of the way PPHM runs their business. Having a manufacturing plant AVID, and holding a good size of cash and pipeline, phase III fast track included, and no major debt. This is why they were able to make this 1st ever special type of financing using preferred shares in the history of biotech. And PPHM a small cap biotech company at that!

    PPHM is becoming a 1st in many new future products for having breaking news in creating the next new cancer fighting drugs..Investors will be rewarded as the new cancer drugs becomes a reality.

    Sentiment: Strong Buy

  • Reply to

    Proof Stock Vader Is A Fraud!

    by swalchie Mar 23, 2014 3:47 PM
    surfer_bj surfer_bj Mar 23, 2014 4:27 PM Flag

    Most likely he wants to buy more long cheap shares while he can...You'd think that this would be the time anyone short would cover at this stage of monthly scripts rising and ads + future news of more country's that could come on board at anytime.

    The risk is far to great to be holding a short as the stock price can move up much higher than it can move down. I remember when APPLE'S stock held between $10/$20. Than one day everything reversed and shorts were left wondering what happened to their short theory?

    ARNA has the same type of future that can shock a shorts theory right out of the ball park and cripple their egoistic mannerism before you can say "I Told You So".

    Sentiment: Strong Buy

  • Reply to

    THEY CANT COVER WHEN WE SAY ENUFF GAMES

    by loucaserin2014 Mar 20, 2014 3:37 PM
    surfer_bj surfer_bj Mar 20, 2014 3:44 PM Flag

    Scripts are possible better, that's why shorts took it down to cover....also with ads coming out soon...who would want to be short at this point. Take cover now while they can.......

    Sentiment: Strong Buy

  • Reply to

    All this excitement over a dime?

    by pphmblingbling Mar 19, 2014 12:40 PM
    surfer_bj surfer_bj Mar 19, 2014 9:11 PM Flag

    I hope 3 years will be way beyond everyone's lifetime, when Phase III is completed:
    SUNRISE ("Stimulating ImmUne RespoNse thRough BavItuximab in a PhaSE III Lung Cancer Study") is a Phase III, global, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the safety, tolerability and efficacy of bavituximab plus docetaxel in patients with second-line non-small cell lung cancer (NSCLC).

    The trial is evaluating bavituximab plus docetaxel versus docetaxel plus placebo in approximately 600 patients at more than 100 clinical sites worldwide. Patients with Stage IIIb/IV non-squamous, NSCLC who have progressed after standard front-line treatment are eligible for enrollment. Patients will be randomized into 1 of 2 treatment arms. All patients will receive up to six 21-day cycles of docetaxel (75 mg/m2) plus weekly infusions of either bavituximab (3mg/kg) or placebo until progression or toxicity. The primary endpoint of the trial will be overall survival. (Let us pray for their survival.)

    Sentiment: Strong Buy

  • surfer_bj surfer_bj Mar 19, 2014 1:39 PM Flag

    Analyst sentiment is moving in the right way. Zacks Rank #2 (Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks.
    From Zacks Article

    Sentiment: Strong Buy

  • Reply to

    All this excitement over a dime?

    by pphmblingbling Mar 19, 2014 12:40 PM
    surfer_bj surfer_bj Mar 19, 2014 1:12 PM Flag

    For every 500 shares that is $50. Someone bought over 6000 shares after hours last night so that dime is over $600. Go take a math class and you can get excited too....

    Sentiment: Strong Buy

  • After Hours Time (ET) After Hours Price After Hours Share Volume 19,169
    19:55 $ 2.28 1,300
    18:36 $ 2.25 160
    18:36 $ 2.25 240
    17:05 $ 2.29 High 200

    ***16:53 $ 2.28 4,496***
    ***16:47 $ 2.24 Low 3,500***

    16:47 $ 2.26 500
    16:40 $ 2.26 500
    16:30 $ 2.24 1,000

    ***16:29 $ 2.2803 6,529**
    *
    16:29 $ 2.2803 144
    16:18 $ 2.26 25
    16:14 $ 2.25 75
    16:10 $ 2.26 300
    16:10 $ 2.26

    Sentiment: Strong Buy

  • Reply to

    Attention Longs

    by americandad71 Mar 16, 2014 2:07 PM
    surfer_bj surfer_bj Mar 16, 2014 10:54 PM Flag

    We were over $5 last year with only no phase III (Fast Track), much smaller pipeline, less cash, and Avid continues adding clients with backorders.

    PPHM was the "1st Biotech company To Ever Sell Preferred Shares in U. S. History" per CEO stated in his the quarterly transcript.

    Sentiment: Strong Buy

ASTX
8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.